While the 1984 Act has been a boon for lower-cost generics, its goal of incentivizing new drug discovery has failed.
Traci Medford-Rosow
Advertisement
Articles by Traci Medford-Rosow
FTC v. Actavis: The Wrong End of the Telescope
Published: | Updated:
On December 8, 2012, the Supreme Court agreed to hear the Federal Trade Commission (FTC) v. Actavis, Inc. case.
Advertisement
Latest Updated Articles
- FTC v. Actavis: The Wrong End of the Telescope
Published: March 25th 2014 | Updated: November 15th 2020
Is the Hatch-Waxman System Broken?Published: January 6th 2016 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
4
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
5